Adenoscan Related Published Studies
Well-designed clinical trials related to Adenoscan (Adenosine)
Preconditioning effects of adenosine in patients with severe coronary artery disease but preserved coronary flow reserve. [2009.08]
Effect of adenosine 5'-triphosphate infusions on the nutritional status and survival of preterminal cancer patients. [2009.08]
Adenosine modulates oesophageal sensorimotor function in humans. [2009.08]
Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol. [2009.07]
Application of a shortened inhaled adenosine-5'-monophosphate challenge in young children using the forced oscillation technique. [2009.07]
Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection. [2009.06]
Maximal response plateau to adenosine 5'-monophosphate in asthma. Relationship with the response to methacholine, exhaled nitric oxide, and exhaled breath condensate pH. [2009.06]
Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia. [2009.05]
Head to head comparisons of two modalities of perfusion adenosine stress echocardiography with simultaneous SPECT. [2009.04.20]
Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus. [2009.04]
Plaque retention by self-ligating vs elastomeric orthodontic brackets: quantitative comparison of oral bacteria and detection with adenosine triphosphate-driven bioluminescence. [2009.04]
Effect of levocetirizine on nasal provocation testing with adenosine monophosphate compared with allergen challenge in allergic rhinitis. [2009.03]
No effect of nutritional adenosine receptor antagonists on exercise performance in the heat. [2009.02]
First-pass dynamic contrast-enhanced MRI with extravasating contrast reagent: evidence for human myocardial capillary recruitment in adenosine-induced hyperemia. [2009.02]
The RegEx trial: a randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging. [2009.01]
The myocardial protective effects of a moderate-potassium adenosine-lidocaine cardioplegia in pediatric cardiac surgery. [2008.12]
Phase 2, double-blind, placebo-controlled, dose-response trial of intravenous adenosine for perioperative analgesia. [2008.12]
Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss: a pilot, double-blind, randomized, placebo-controlled trial. [2008.12]
The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. [2008.10]
Positron emission tomography analysis of [11C]KW-6002 binding to human and rat adenosine A2A receptors in the brain. [2008.09]
The reproducibility of adenosine monophosphate bronchial challenges in mild, steroid-naive asthmatics. [2008.08]
Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial. [2008.05]
Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial). [2008.05]
Methacholine vs adenosine on intra and extrathoracic airway hyperresponsiveness in patients with cough variant asthma. [2008.05]
Hepatic fat and adenosine triphosphate measurement in overweight and obese adults using 1H and 31P magnetic resonance spectroscopy. [2008.05]
Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. [2008.05]
Initial results of a clinical study: adenosine enhanced cardioprotection and its effect on cardiomyocytes apoptosis during coronary artery bypass grafting. [2008.04]
Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005). [2008.03]
High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo-controlled pilot study. [2008.02.15]
Intracoronary adenosine improves myocardial perfusion in late reperfused myocardial infarction. [2008.02.05]
Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial. [2008.01]
Effect of an inhaled adenosine A2A agonist on the allergen-induced late asthmatic response. [2008.01]
Effects of airway anesthesia on dyspnea and ventilatory response to intravenous injection of adenosine in healthy human subjects. [2008]
Clinical Evidence for Utilization of the A3 Adenosine Receptor as a Target to Treat Rheumatoid Arthritis: Data from a Phase II Clinical Trial. [2007.11.15]
Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial. [2007.11.06]
Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients. [2007.11]
beta-Endorphin modulates adenosine provoked chest pain in men, but not in women-a comparison between patients with ischemic heart disease and healthy volunteers. [2007.11]
The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. [2007.10.16]
The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment. [2007.10]
[Adenosine preconditioning reduces myocardial injury in patients undergoing off-pump coronary artery bypass grafting surgery] [2007.09.04]
Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. [2007.09]
Therapeutic benefit of low-dose clopidogrel in patients undergoing carotid surgery is linked to variability in the platelet adenosine diphosphate response and patients' weight. [2007.09]
Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study. [2007.08.14]
Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study. [2007.06.19]
Coronary circulation responses to binodenoson, a selective adenosine A2A receptor agonist. [2007.06.01]
Postconditioning the human heart with adenosine in heart valve replacement surgery. [2007.06]
Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. [2007.06]
Local effect of adenosine 5'-triphosphate on indomethacin-induced permeability changes in the human small intestine. [2007.03]
Formulation, characterization, and efficacy of an adenosine-containing dissolvable film for a localized anti-wrinkle effect. [2007.03]
Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning. [2007.03]
Application of adenosine 5'-triphosphate (ATP) infusions in palliative home care: design of a randomized clinical trial. [2007.01.08]
Diagnostic yield of adenosine and nitroglycerine stimulated tilt test in patients with unexplained syncope. [2007]
The effect of challenge method on sensitivity and reactivity to adenosine 5'-monophosphate in subjects with suspected asthma. [2006.11]
Adenosinergic mechanisms contribute to individual differences in sleep deprivation-induced changes in neurobehavioral function and brain rhythmic activity. [2006.10.11]
Transthoracic coronary flow velocity reserve assessment: comparison between adenosine and dobutamine. [2006.10]
Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes. [2006.09]
Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis. [2006.09]
Detection of significant stenotic lesions in the left anterior descending coronary artery using adenosine triphosphate stress strain imaging: comparison with coronary flow velocity reserve measurement using transthoracic Doppler echocardiography. [2006.08]
Post-reperfusion myocardial infarction: long-term survival improvement using adenosine regulation with acadesine. [2006.07.04]
Adenosine cardioprotection study in clinical setting of paroxysmal supraventricular tachycardia. [2006.06]
Efficacy of intrathecal adenosine for postoperative pain relief. [2006.06]
Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation. [2006.04]
Quantitative adenosine real-time myocardial contrast echocardiography for detection of angiographically significant coronary artery disease. [2006.04]
Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure. [2006.04]
Adenosine A1 receptor antagonist improves intradialytic hypotension. [2006.03]
Effect of omalizumab on adenosine 5'-monophosphate responsiveness in subjects with allergic asthma. [2006]
Bolus injection of adenosine before cardioplegic induction improves postischemic global function in coronary artery bypass grafting. [2005.12]
Bronchial plasma exudation after adenosine monophosphate or methacholine challenge. [2005.12]
Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting. [2005.11.15]
Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants. [2005.11.05]
Left ventricular remodeling after primary coronary angioplasty in patients treated with abciximab or intracoronary adenosine. [2005.11]
Urinary cyclic guanosine 3',5'-monophosphate and cyclic adenosine 3',5'-monophosphate changes in spontaneous and induced onset active labor. [2005.11]
Effects of aerosolized adenosine 5'-triphosphate vs adenosine 5'-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma. [2005.10]
Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial. [2005.10]
Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole. [2005.10]
Effect of salbutamol on nasal symptoms and mast cell degranulation induced by adenosine 5' monophosphate nasal challenge. [2005.09]
Effect of histamine and adenosine 5'-monophosphate provocation on sputum neutrophils and related mediators in atopic patients. [2005.08]
A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). [2005.06.07]
Dose-response comparison of budesonide dry powder inhalers using adenosine monophosphate bronchial challenge. [2005.06]
A randomized, double-blind, placebo controlled triphosphate in study of oral adenosine subacute low back pain. [2005.06]
Potentiation of uterine effects of prostaglandin F2{alpha} by adenosine 5'-triphosphate. [2005.06]
Does adenosine pharmacologically precondition human myocardium during coronary bypass surgery? [2005.06]
The effect of circulating adenosine on cerebral haemodynamics and headache generation in healthy subjects. [2005.05]
Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. [2005.04]
Sildenafil prevents endothelial dysfunction induced by ischemia and reperfusion via opening of adenosine triphosphate-sensitive potassium channels: a human in vivo study. [2005.02.15]
The effect of adenosine triphosphate on vecuronium-induced neuromuscular block. [2005.01]
Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients. [2005]
High-dose adenosine infusion provokes oscillations of chest pain without correlation to opioid modulation: a double-blind controlled study. [2004.11]
Regulation of renal adenosine excretion in humans--role of sodium and fluid homeostasis. [2004.11]
Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? [2004.10]
The effect of intravenous infusion of adenosine on electrically evoked hyperalgesia in a healthy volunteer model of central sensitization. [2004.09]
Adenosine sestamibi SPECT post-infarction evaluation (INSPIRE) trial: A randomized, prospective multicenter trial evaluating the role of adenosine Tc-99m sestamibi SPECT for assessing risk and therapeutic outcomes in survivors of acute myocardial infarction. [2004.07]
The fixed combination of valerian and hops (Ze91019) acts via a central adenosine mechanism. [2004.07]
Single and short-term dosing effects of levocetirizine on adenosine monophosphate bronchoprovocation in atopic asthma. [2004.07]
Role of endogenous adenosine in atrial fibrillation after coronary artery bypass graft. [2004.06]
Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis. [2004.06]
Effect of diazepam on adenosine 3',5'-cyclic monophosphate (cAMP) plasma levels in anesthetized patients. [2004.05]
Pharmacokinetics, pharmacodynamics, and safety of a lipid-lowering adenosine A1 agonist, RPR749, in healthy subjects. [2004.05]
[Comparison of myocardial perfusion imaging by thallium-201 single-photon emission computed tomography with SUNY4001 (adenosine) and exercise--crossover clinical trial at multi-center] [2004.05]
Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis. [2004.04]
Experimentally induced ischaemic pain in healthy humans is attenuated by the adenosine receptor antagonist theophylline. [2004.03]
|
